Overall KFDA reforms including clinical study system planned to complete earlier.

Published: 1999-04-07 17:56:00

Updated: 1999-04-07 17:56:00

Mr. Choi Soo-young, the director of Drug Safety Bureau of KFDA, addressed a lecture at the 45th anniversary meeting of Yakup Shinmoon foundation under the title of "the pharmaceutical issues and policies in 21st century", stressing that the drug safety administration policy would be focused more ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK